성장호르몬 결핍 성인에서 성장호르몬 투여가 심혈관 질환의 표지자에 미치는 영향

키워드

참고문헌 (26)

1. "Premature mortality due to cardiovascular disease in hypopituitarism", 336, pp.285~288 (1990)
2. "Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults", 84, pp.453~457 (1999)
3. "Endothelial dysfunction in hypopituitary adults with growth hormone deficiency", 50, pp.457~464 (1999)
4. "Cardiovascular disease and risk factors in adults with hypopituitarism", 50, pp.1~15 (1999)
5. "Atherosclerosis", 340, pp.115~126 (1999)
6. "Evaluating novel cardiovascular risk factors", 130, pp.933~937 (1999)
7. "The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors", 91, pp.425~437 (2004)
8. "Assessment of quality of life in adults receiving long-term growth hormone replacement compared to control subjects", 59, pp.75~81 (2003)
9. "Estimation of the concentration of low lipoprotein in plasma without use of preparative ultracentrifuge", pp.499~502 (1972)
10. "Decrease in carotid intima-media thickness after one year growth hormone treatment in adults with GH deficiency", 84, pp.1329~1333 (1999)
11. "Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model", 130, pp.1115~1122 (1995)
12. "Growth hormone attenuates the acute-phase response to thermal injury", 132, pp.1171~1175 (1997)
13. "Adipose tissue as an endocrine and paracrine organ", 22, pp.1145~1158 (1998)
14. "Adipose expression of tumor necrosis factor-α:direct role in obesity-linked insulin resistance", 259, pp.87~91 (1993)
15. "Tumor necrosis factor-α:a key component of the obesity-diabetes link", 43, pp.1271~1278 (1994)
16. "Plasminogen activator inhibitor in plasma:risk factor for recurrent myocardial infarction", 2, pp.3~9 (1987)
17. "Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris", 332, pp.635~641 (1995)
18. "Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency", 125, pp.883~890 (1996)
19. "Treatment of adults with growth hormone deficiency with recombinant human GH", j clin endocri(l metab 76), pp.309~317 (1993)
20. "Cardiovascular and renal effects of growth hormone", 40, pp.393~400 (1994)
21. "Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults", 15, pp.2142~2150 (1995)
22. "The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency", 137(l 137), pp.459~466 (1997)
23. "The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance", 80, pp.356~363 (1995)
24. "A prospective study of 5 years of GH replacement therapy in GH-deficient adults", 86, pp.4657~4665 (2001)
25. "Long-term monitoring of insulin sensitivity in growth hormone- deficient adults on substitutive recombinant human growth hormone therapy", 53, pp.740~743 (2004)
26. "Application of a disease-specific, quality- of-life measure (QoL-AGHDA) in grwoth hormone- deficient adults and a random population sample in Sweden", 52, pp.141~142 (2000)

관련 논문AI추천